Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer in January 2006 and is headquartered in Nashville, TN.
Show more...
FAQ
Harrow Health 8.625% Senior Notes due 2026 今天的股價是多少?▼
HROWL 目前價格為 $25.61 USD,過去 24 小時上漲了 +0.19%。在圖表上更密切關注 Harrow Health 8.625% Senior Notes due 2026 股價表現。
Harrow Health 8.625% Senior Notes due 2026 的股票代號是什麼?▼
根據交易所不同,股票代號可能會有所差異。例如,在 交易所,Harrow Health 8.625% Senior Notes due 2026 的股票以代號 HROWL 進行交易。
Harrow Health 8.625% Senior Notes due 2026 的股價在上漲嗎?▼
HROWL 股票較上週上漲 +0%,本月上漲 +0%,過去一年 Harrow Health 8.625% Senior Notes due 2026 上漲 +0.87%。
Harrow Health 8.625% Senior Notes due 2026 去年的營收是多少?▼
Harrow Health 8.625% Senior Notes due 2026 去年的營收為 199.61MUSD。
Harrow Health 8.625% Senior Notes due 2026 去年的淨利是多少?▼
HROWL 去年的淨收益為 -17.48MUSD。
Harrow Health 8.625% Senior Notes due 2026 會發放股息嗎?▼
是的,HROWL 的股息每 每季 發放一次。每股最新股息為 0.54 USD。截至今日,股息殖利率(FWD)% 為 8.42%。
Harrow Health 8.625% Senior Notes due 2026 有多少名員工?▼
截至 April 03, 2026,公司共有 217 名員工。
Harrow Health 8.625% Senior Notes due 2026 位於哪個產業?▼
Harrow Health 8.625% Senior Notes due 2026從事於Health Care產業。
Harrow Health 8.625% Senior Notes due 2026 何時完成拆股?▼
Harrow Health 8.625% Senior Notes due 2026 最近沒有進行任何拆股。